MedTech Business - June 9, 2026
Medicvent secures major hospital contracts in Sweden and France
The company has secured two major hospital contracts in Sweden and France, with a combined value of approximately SEK 16 million.
Collaboration - June 8, 2026
Moberg Pharma and Karo Healthcare expand collaboration for MOB-015/Terclara to China
Moberg Pharma has entered into a license agreement with Karo Healthcare regarding the commercialization of the nail fungus drug MOB-015 (Terclara) in China through the rapidly growing cross-border e-commerce channel.
Agreement - May 26, 2026
Oncopeptides signs agreement with Salus
The agreement for distribution and commercialization of Pepaxti in Central and Eastern Europe addresses a market potential of approximately SEK 150 million and enables potential sales uptake in this region earlier than previously planned, the company states.
New Market - May 20, 2026
Lundbeck receives orphan drug designation in Japan
The orphan drug designation has been granted for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing’s disease.
MedTech Business - May 6, 2026
Encare sets its sights on the USA
When Encare was awarded the Swecare Export Award 2026, the company was highlighted as one of the Swedish healthtech companies that has succeeded in translating clinical research into concrete benefits in healthcare internationally.
Business article - April 7, 2026
Zealand Pharma establishes US Research Hub in Cambridge
The new research hub in Cambridge, Massachusetts, in the greater Boston area, will serve as Zealand Pharma’s primary US address and is expected to be operational from September 2026.
